Close Menu

You may find more results for this query on our sister sites: GenomeWeb and 360Dx.

Home › Tools & Technology › Sequencing › Veterans With Targetable Mutations in Lung Cancer Not Getting Right Rx, Study Finds

Veterans With Targetable Mutations in Lung Cancer Not Getting Right Rx, Study Finds

Jun 03, 2020
|
Andrea Anderson

NEW YORK – A significant proportion of non-small cell lung cancer patients being evaluated through the Veterans Health Administration's National Precision Oncology Program (NPOP) are not prescribed targeted therapies for actionable variants in their tumors, new research suggests.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Apr
27
Featured Webinar

Oncology in the Time of COVID-19: Quantitative Proteomic Analysis of Anti-IL6 Treated Patients

Sponsored by
Biognosys

This webinar, the first in our Next-Generation Proteomics for Precision Oncology series, will discuss how proteomics can help overcome the challenges of treating COVID-19 patients with oncologic comorbidities.

May
26
Featured Webinar

CaTCH it if you can! CRISPRa-based Exploration of Therapy Resistant Cell Clones

Sponsored by
Lexogen

The emergence of cell clones that are resistant to targeted therapies poses a significant issue in the treatment of metastatic melanoma.

What's Popular?

In Sequencing

  1. With Support From Lawmakers, WGS Becoming More Accessible to Netherlands' Cancer Patients

    Premium

  2. Gene Expression Score IDs PD-1/PD-L1 Immune Checkpoint Inhibitor Resistance in Bladder Cancers

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.